These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27930500)

  • 1. Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.
    Rezaei Ardani A; Hosseini G; Fayyazi Bordbar MR; Talaei A; Mostafavi Toroghi H
    J Clin Psychopharmacol; 2017 Feb; 37(1):54-60. PubMed ID: 27930500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial.
    Baniasadi M; Hosseini G; Fayyazi Bordbar MR; Rezaei Ardani A; Mostafavi Toroghi H
    J Psychiatr Pract; 2014 Nov; 20(6):419-27. PubMed ID: 25406046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
    Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F
    J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine as an effective add-on to standard treatment of veterans with chronic posttraumatic stress disorder: a case series.
    Fayyazi Bordbar MR; Talaei A
    J Clin Psychopharmacol; 2013 Oct; 33(5):706-9. PubMed ID: 23948788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.
    Maguire PA; Bastiampillai T; Allison S; Wilkes F; Looi JCL
    East Asian Arch Psychiatry; 2024 Jun; 34(2):29-36. PubMed ID: 38955788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
    Davis LL; Jewell ME; Ambrose S; Farley J; English B; Bartolucci A; Petty F
    J Clin Psychopharmacol; 2004 Jun; 24(3):291-7. PubMed ID: 15118483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder.
    Manteghi AA; Hebrani P; Mortezania M; Haghighi MB; Javanbakht A
    J Clin Psychopharmacol; 2014 Apr; 34(2):240-3. PubMed ID: 24525635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
    Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
    Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
    Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
    BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial.
    English BA; Jewell M; Jewell G; Ambrose S; Davis LL
    J Clin Psychopharmacol; 2006 Feb; 26(1):84-8. PubMed ID: 16415713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Henderson EJ; Lord SR; Brodie MA; Gaunt DM; Lawrence AD; Close JC; Whone AL; Ben-Shlomo Y
    Lancet Neurol; 2016 Mar; 15(3):249-58. PubMed ID: 26795874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
    Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD;
    J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
    Schneier FR; Campeas R; Carcamo J; Glass A; Lewis-Fernandez R; Neria Y; Sanchez-Lacay A; Vermes D; Wall MM
    Depress Anxiety; 2015 Aug; 32(8):570-9. PubMed ID: 26115513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
    Brawman-Mintzer O; Tang XC; Bizien M; Harvey PD; Horner MD; Arciniegas DB; Raskind M; Johnson-Greene L; Martineau RJ; Hamner M; Rodriguez-Suarez M; Jorge RE; McGarity S; Wortzel HS; Wei Y; Sindowski T; Mintzer J; Kindy AZ; Donovan K; Reda D
    J Neurotrauma; 2021 Jul; 38(14):1943-1952. PubMed ID: 33514274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: Assessor-blinded, randomized controlled study.
    Feng B; Zhang Y; Luo LY; Wu JY; Yang SJ; Zhang N; Tan QR; Wang HN; Ge N; Ning F; Zheng ZL; Zhu RM; Qian MC; Chen ZY; Zhang ZJ
    Psychiatry Clin Neurosci; 2019 Apr; 73(4):179-186. PubMed ID: 30565342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No interaction between rivastigmine and citalopram on memory and novelty processing in healthy human volunteers.
    Heckman P; Blokland A; Sambeth A
    J Psychopharmacol; 2019 Feb; 33(2):210-218. PubMed ID: 30226087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.
    Mowla A; Mosavinasab M; Haghshenas H; Borhani Haghighi A
    J Clin Psychopharmacol; 2007 Oct; 27(5):484-7. PubMed ID: 17873681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.